Sentosa Geigy (India) Labs Profile
Key Indicators
- Authorised Capital ₹ 0.50 M
as on 18-07-2024
- Paid Up Capital ₹ 0.50 M
as on 18-07-2024
- Company Age 14 Year, 10 Months
- Last Filing with ROC 31 Mar 2023
- Revenue 72.16%
(FY 2020)
- Profit 67.25%
(FY 2020)
- Ebitda 41.59%
(FY 2020)
- Net Worth 41.72%
(FY 2020)
- Total Assets 177.93%
(FY 2020)
About Sentosa Geigy (India) Labs
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 0.50 M and a paid-up capital of Rs 0.50 M, as per Ministry of Corporate Affairs (MCA) records.
Naresh Goel, Ramesh Goel, and Mohit Goel serve as directors at the Company.
- CIN/LLPIN
U24230DL2010PLC198616
- Company No.
198616
- Company Classification
Public Limited Indian Non-Government Company
- Incorporation Date
02 Feb 2010
- Date of AGM
28 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
Company Details
- Location
Delhi, Delhi, India
- Telephone
- Email Address
- Website
- Social Media-
Who are the key members and board of directors at Sentosa Geigy (India) Labs?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Naresh Goel  | Director | 02-Feb-2010 | Current |
| Ramesh Goel | Director | 02-Feb-2010 | Current |
| Mohit Goel | Director | 10-Oct-2013 | Current |
Financial Performance and Corporate Structure Insights of Sentosa Geigy (India) Labs.
Sentosa Geigy (India) Labs Limited, for the financial year ended 2020, experienced significant growth in revenue, with a 72.16% increase. The company also saw a substantial improvement in profitability, with a 67.25% increase in profit. The company's net worth Soared by an impressive increase of 41.72%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Sentosa Geigy (India) Labs?
In 2020, Sentosa Geigy (India) Labs had a promoter holding of 20.04% and a public holding of 79.96%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Recova Pharma Expo Private LimitedActive 18 years 9 monthsNaresh Goel and Ramesh Goel are mutual person
Sun Medilab Private LimitedActive 17 years 10 daysNaresh Goel, Ramesh Goel and 1 more are mutual person
- Warner India Lifesciences LimitedActive 13 years 3 months
Naresh Goel and Mohit Goel are mutual person
- Shrish Enterprises Private LimitedActive 24 years 8 months
Naresh Goel and Ramesh Goel are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Sentosa Geigy (India) Labs?
Unlock and access historical data on people associated with Sentosa Geigy (India) Labs, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Sentosa Geigy (India) Labs, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Sentosa Geigy (India) Labs's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
